Eva Szegezdi

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Acinetobacter Baumannii

Chronic Lymphocytic Leukemia

Intensive Care Unit

Top Venues

Scientific reports

British journal of haematology

National University of Ireland - Galway

University of Debrecen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National University of Ireland - Galway Mar 01 2017

Ireland

Lecturer in Cancer Research :: Biochemistry

National University of Ireland - Galway Oct 01 2001 - Sep 05 2011

Ireland

Postdoctoral researcher :: Biochemistry

University of Debrecen Dec 15 2000 - Sep 30 2001

Hungary

Postdoctoral researcher :: Biochemistry

Education History

University of Debrecen Sep 01 1996 - Dec 12 2000

Hungary

PHD :: Biochemistry

University of Debrecen, Hungary Sep 01 1990 - Jun 30 1996

Hungary

MSC :: Biochemistry

Publications

Pramath Kakodkar, Sanket More, Kinga András, Nikos Papakonstantinou, Sharon Kelly, Mohammad Adib Makrooni, Csaba Ortutay, Eva Szegezdi
Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia. Cancers 12 (7) (2020)
Sukhraj Pal Singh Dhami, Andrea Tirincsi, Denis Baev, Janusz Krawczyk, John Quinn, Mary R Cahill, Dimitrios I Zeugolis, Eva Szegezdi
Theranostic drug test incorporating the bone-marrow microenvironment can predict the clinical response of acute myeloid leukaemia to chemotherapy. British journal of haematology 189 (6) (2020)
Eimear O' Reilly, Sukhraj Pal S Dhami, Denis V Baev, Csaba Ortutay, Anna Halpin-McCormick, Ruth Morrell, Corrado Santocanale, Afshin Samali, John Quinn, Michael E O'Dwyer, Eva Szegezdi
Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML. Scientific reports 8 (1) (2018)